Tuesday, April 21, 2015
Personalized Medicine: Our Human Genome
Personalized medicine can help diagnose many different types of cancers, some forms of Alzheimer’s disease, HIV/AIDS and many other diseases. This range to cure seems to be limitless. Over the past 20 years the price of genome sequencing has gone down from a few million dollars to a few thousand dollars, making it much more accessible to patients. The increase of genomic data and understanding of how genes contribute to diseases improve clinical decisions and patient care. With more research, genome sequencing can also contribute to other area of science and innovation.
The Brigham Research Institute (BRI) at Brigham and Women’s Hospital will host a symposium on “The Future of Genetics in Healthcare: From Sequencing to Treatment” highlighting science from our community in areas such as DNA sequencing, precision medicine, global phenotyping and more. Speakers include Calum Macrae M.D PhD, Robert Green M.D MPH, Tamarra James-Todd PhD and Raju Kucherlapati PhD. Join us this Thursday, April 23 to learn more from experts in one of the leading healthcare fields and hear about how the science of today will impact patient care in the future.
Register for the event here.
Piece by Alessandra Maahs Co-op Intern at the Brigham Research Institute at Brigham and Women’s Hospital with a focus in Biology and Communications.
at 10:00 AM